Hualan Biological Engineering Inc.
002007
Ранг среди акций
#4386
Hualan Biological Engineering Inc. operates as a biopharmaceutical company,... Hualan Biological Engineering Inc. operates as a biopharmaceutical company, specializing in the research, development, production, and commercialization of a diverse portfolio of medical products within the People's Republic of China. Its offerings span plasma-derived therapies, various viral and bacterial vaccines, recombinant proteins, and other advanced biologics. The company's extensive range of plasma products includes essential components like human albumin, a broad spectrum of human immunoglobulins (such as intravenous, rabies, hepatitis B, and tetanus formulations), and vital coagulation factors like human prothrombin complex and factor VIII. Hualan also provides specialized solutions such as lyophilized human thrombin for external use and surgical fibrin glue. In its vaccine division, Hualan offers critical immunizations, including several influenza vaccines (e.g., split virus, A H1N1, and quadrivalent forms), recombinant hepatitis B vaccine, and ACYW135 meningococcal polysaccharide vaccine. The company actively pursues strategic collaborations with key scientific organizations, most notably the Chinese Academy of Sciences, as well as other esteemed research institutes and enterprises. Established in 1992, Hualan Biological Engineering Inc. is headquartered in Xinxiang, People's Republic of China.
Цена акции
$1.92
Рыночная капитализация
$3.50B
Изменение (1 день)
-1.39%
Изменение (1 год)
-19.45%
Страна
CN
Торговля Hualan Biological Engineering Inc. (002007)
Категория
Healthcare
Коэффициент P/B для Hualan Biological Engineering Inc. (002007)
Коэффициент P/B на October 2026 TTM: 2.13
Согласно последним финансовым отчетам и цене акций Hualan Biological Engineering Inc., текущий коэффициент P/B (TTM) составляет 2.13. В конце 2024 он составлял 2.59.
История P/B для Hualan Biological Engineering Inc. с 2001 по 2026
Коэффициент P/B в конце каждого года
| Год | P/B | Изменить |
|---|---|---|
| 2026 (TTM) | 2.13 | -11.18% |
| 2025 | 2.40 | -7.39% |
| 2024 | 2.59 | -27.01% |
| 2023 | 3.55 | -10.48% |
| 2022 | 3.97 | -37.62% |
| 2021 | 6.36 | -37.60% |
| 2020 | 10.20 | 35.87% |
| 2019 | 7.51 | 49.25% |
| 2018 | 5.03 | -10.18% |
| 2017 | 5.60 | -28.94% |
| 2016 | 7.88 | 12.72% |
| 2015 | 6.99 | 22.97% |
| 2014 | 5.69 | 5.58% |
| 2013 | 5.38 | 15.44% |
| 2012 | 4.66 | -23.42% |
| 2011 | 6.09 | -52.62% |
| 2010 | 12.85 | 7.25% |
| 2009 | 11.99 | 55.58% |
| 2008 | 7.70 | -57.54% |
| 2007 | 18.15 | 186.87% |
| 2006 | 6.33 | 322.88% |
| 2005 | 1.50 | 22.78% |
| 2004 | 1.22 | -75.16% |
| 2003 | 4.90 | -27.47% |
| 2002 | 6.76 | -30.90% |
| 2001 | 9.79 | 0.00% |
Коэффициент P/B для аналогичных компаний или конкурентов
| Компания | P/B | Разница P/B | Страна |
|---|---|---|---|
| 6.251 | 193.25% |
US
|
|
| 13.2547 | 521.82% |
US
|
|
| 4.4521 | 108.86% |
AU
|
|
| 6.3632 | 198.52% |
NL
|
|
| 3.2932 | 54.49% |
BE
|
